Search research articles
Contact Us
Filters
Showing results (351-360 of 393) with videos related to
Page
of 40
Sort By:
Journal for Immunotherapy of Cancer
|
May 8, 2021
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy
Karan Kohli, Lu Yao, Theodore Scott Nowicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2016
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma
Christopher W Ryan, Ofer Merimsky, Mark Agulnik, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 4, 2023
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022
Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, et al.
Clinical and Translational Medicine
|
July 15, 2022
Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biology
Samuel V Rasmussen, Jia Xiang Jin, Lissett R Bickford, et al.
JAMA Oncology
|
October 16, 2025
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review
César Serrano, Sebastian Bauer, Jean-Yves Blay, et al.
BMJ Open
|
May 4, 2026
Pre-diagnostic route reported by patients with sarcoma from the Netherlands, the UK, Australia and New Zealand: early detection challenges for general practitioners - an international observational cohort study
Emily I Holthuis, Vicky L M N Soomers, Meena Rafiq, et al.
The Lancet. Oncology
|
October 9, 2020
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
Mrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Frontiers in Oncology
|
June 5, 2026
Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case series
Jessica S Zhang, Juliana C K Ng, Pedro Hermida de Viveiros, et al.
Cancer
|
May 3, 2017
T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas
Seth M Pollack, Qianchuan He, Jennifer H Yearley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 20, 2023
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
Hans Gelderblom, Robin L Jones, Jean-Yves Blay, et al.
Page
of 40
Search research articles
Search
Showing results (351-360 of 393) with videos related to
Sort By:
Page
of 40
Journal for Immunotherapy of Cancer
|
May 8, 2021
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy
Karan Kohli, Lu Yao, Theodore Scott Nowicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2016
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma
Christopher W Ryan, Ofer Merimsky, Mark Agulnik, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 4, 2023
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022
Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, et al.
Clinical and Translational Medicine
|
July 15, 2022
Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biology
Samuel V Rasmussen, Jia Xiang Jin, Lissett R Bickford, et al.
JAMA Oncology
|
October 16, 2025
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review
César Serrano, Sebastian Bauer, Jean-Yves Blay, et al.
BMJ Open
|
May 4, 2026
Pre-diagnostic route reported by patients with sarcoma from the Netherlands, the UK, Australia and New Zealand: early detection challenges for general practitioners - an international observational cohort study
Emily I Holthuis, Vicky L M N Soomers, Meena Rafiq, et al.
The Lancet. Oncology
|
October 9, 2020
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
Mrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Frontiers in Oncology
|
June 5, 2026
Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case series
Jessica S Zhang, Juliana C K Ng, Pedro Hermida de Viveiros, et al.
Cancer
|
May 3, 2017
T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas
Seth M Pollack, Qianchuan He, Jennifer H Yearley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 20, 2023
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
Hans Gelderblom, Robin L Jones, Jean-Yves Blay, et al.
Page
of 40